help button home button Am J Pathol JNCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monteagudo, C.
Right arrow Articles by Stetler-Stevenson, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monteagudo, C.
Right arrow Articles by Stetler-Stevenson, W. G.

American Journal of Pathology, Vol 136, 585-592, Copyright © 1990 by American Society for Investigative Pathology

REGULAR ARTICLES

Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue

C Monteagudo, MJ Merino, J San-Juan, LA Liotta and WG Stetler-Stevenson
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

Production of type IV collagenase by tumor cells has been linked to their metastatic potential in several experimental models. A possible role for this enzyme in basement membrane type IV collagen turnover has also been suggested. Two recently developed affinity-purified, monospecific antibodies directed against the amino terminus (H1), or an internal active site domain (metal binding region [MBR]) of human type IV collagenase, were employed in the avidin-biotin-immunoperoxidase technique in formalin-fixed, paraffin-embedded breast tissue samples from 55 patients. Intense cytoplasmic immunostaining of myoepithelial cells was found in normal and hyperplastic tissue, and discontinuous staining was noted in intraductal carcinomas. Luminal epithelial cells were negative or weakly positive in large- or medium-sized ducts but reacted frequently in normal terminal ducts and hyperplastic lesions. Epithelial cells in intraductal carcinomas exhibited immunoreactivity in 20 of 23 cases. Invasive carcinomas were positive in 36 of 40 cases, and metastatic cells in lymph nodes stained in 10 of 12 cases. These results support a role for type IV collagenase in the basement membrane remodeling of normal breast. Our findings suggest that myoepithelial cells play a pivotal role in this enzymatic activity. The high percentage of positive cells in invasive carcinomas and the strong immunoreactivity of lymph node metastases support the role of the enzyme in tumor invasion and metastasis and suggest that tumor cells are the essential source of the enzyme in these processes.


This article has been cited by other articles:


Home page
 Reproductive SciencesHome page
Y.-T. Tee, C.-P. Han, J.-L. Ko, G.-D. Chen, S.-F. Yang, S.-C. Chen, H.-J. Tsai, L.-Y. Lin, and P.-H. Wang
Evaluation of Matrix Metalloproteinase 2 Expression in Cervical Carcinogenesis Using Tissue Array and Integrated Optical Density for Immunoreactivity
Reproductive Sciences, October 1, 2007; 14(7): 719 - 726.
[Abstract] [PDF]

Home page
 J. Cell Sci.Home page
C. H. Stuelten, S. D. Byfield, P. R. Arany, T. S. Karpova, W. G. Stetler-Stevenson, and A. B. Roberts
Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-{alpha} and TGF-{beta}
J. Cell Sci., May 15, 2005; 118(10): 2143 - 2153.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
A. Karadag, K. U. E. Ogbureke, N. S. Fedarko, and L. W. Fisher
Bone Sialoprotein, Matrix Metalloproteinase 2, and {alpha}v{beta}3 Integrin in Osteotropic Cancer Cell Invasion
J Natl Cancer Inst, June 16, 2004; 96(12): 956 - 965.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. L. Owen, V. Iragavarapu-Charyulu, Z. Gunja-Smith, L. M. Herbert, J. F. Grosso, and D. M. Lopez
Up-Regulation of Matrix Metalloproteinase-9 in T Lymphocytes of Mammary Tumor Bearers: Role of Vascular Endothelial Growth Factor
J. Immunol., October 15, 2003; 171(8): 4340 - 4351.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
B. Bodner-Adler, K. Bodner, O. Kimberger, K. Czerwenka, S. Leodolter, and K. Mayerhofer
MMP-1 and MMP-2 Expression in Uterine Leiomyosarcoma and Correlation With Different Clinicopathologic Parameters
Reproductive Sciences, October 1, 2003; 10(7): 443 - 446.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
F. Mannello and M. Sebastiani
Zymographic Analyses and Measurement of Matrix Metalloproteinase-2 and -9 in Nipple Aspirate Fluids
Clin. Chem., September 1, 2003; 49(9): 1546 - 1550.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
B. Nawrocki-Raby, C. Gilles, M. Polette, C. Martinella-Catusse, N. Bonnet, E. Puchelle, J.-M. Foidart, F. van Roy, and P. Birembaut
E-Cadherin Mediates MMP Down-Regulation in Highly Invasive Bronchial Tumor Cells
Am. J. Pathol., August 1, 2003; 163(2): 653 - 661.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pathol.Home page
E A Baker, T J Stephenson, M W R Reed, and N J Brown
Expression of proteinases and inhibitors in human breast cancer progression and survival
Mol. Pathol., October 1, 2002; 55(5): 300 - 304.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
K. D. Miller, W. Gradishar, L. Schuchter, J. A. Sparano, M. Cobleigh, N. Robert, H. Rasmussen, and G. W. Sledge
A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer
Ann. Onc., August 1, 2002; 13(8): 1220 - 1224.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S. Ito, T. Fukusato, T. Nemoto, H. Sekihara, Y. Seyama, and S. Kubota
Coexpression of Glucose Transporter 1 and Matrix Metalloproteinase-2 in Human Cancers
J Natl Cancer Inst, July 17, 2002; 94(14): 1080 - 1091.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
C. J. FABIAN and B. F. KIMLER
Beyond Tamoxifen: New Endpoints for Breast Cancer Chemoprevention, New Drugs for Breast Cancer Prevention
Ann. N.Y. Acad. Sci., December 1, 2001; 952(1): 44 - 59.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Määttä, Y. Soini, A. Liakka, and H. Autio-Harmainen
Differential Expression of Matrix Metalloproteinase (MMP)-2, MMP-9, and Membrane Type 1-MMP in Hepatocellular and Pancreatic Adenocarcinoma: Implications for Tumor Progression and Clinical Prognosis
Clin. Cancer Res., July 1, 2000; 6(7): 2726 - 2734.
[Abstract] [Full Text]

Home page
 Mol. Pathol.Home page
E A Garbett, M W R Reed, T J Stephenson, and N J Brown
Proteolysis in human breast cancer
Mol. Pathol., April 1, 2000; 53(2): 99 - 106.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Renal Physiol.Home page
Y. S. Kanwar, K. Ota, Q. Yang, J. Wada, N. Kashihara, Y. Tian, and E. I. Wallner
Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis
Am J Physiol Renal Physiol, December 1, 1999; 277(6): F934 - F947.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Ries, F. Loher, C. Zang, M. G. Ismair, and P. E. Petrides
Matrix Metalloproteinase Production by Bone Marrow Mononuclear Cells from Normal Individuals and Patients with Acute and Chronic Myeloid Leukemia or Myelodysplastic Syndromes
Clin. Cancer Res., May 1, 1999; 5(5): 1115 - 1124.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
G. Giannelli, A. Pozzi, W. G. Stetler-Stevenson, H. A. Gardner, and V. Quaranta
Expression of Matrix Metalloprotease-2-Cleaved Laminin-5 in Breast Remodeling Stimulated by Sex Steroids
Am. J. Pathol., April 1, 1999; 154(4): 1193 - 1201.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Maekawa, H. Maki, H. Yoshida, K. Hojo, H. Tanaka, T. Wada, N. Uchida, Y. Takeda, H. Kasai, H. Okamoto, et al.
Correlation of Antiangiogenic and Antitumor Efficacy of N-biphenyl Sulfonyl-phenylalanine Hydroxiamic Acid (BPHA), an Orally-active, Selective Matrix Metalloproteinase Inhibitor
Cancer Res., March 1, 1999; 59(6): 1231 - 1235.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. E. Stearns, F. U. Garcia, K. Fudge, J. Rhim, and M. Wang
Role of Interleukin 10 and Transforming Growth Factor {beta}1 in the Angiogenesis and Metastasis of Human Prostate Primary Tumor Lines from Orthotopic Implants in Severe Combined Immunodeficiency Mice
Clin. Cancer Res., March 1, 1999; 5(3): 711 - 720.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
G Cox, W P Steward, and K J O'Byrne
The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer
Thorax, February 1, 1999; 54(2): 169 - 179.
[Full Text]

Home page
 Clin. Cancer Res.Home page
T. Iizasa, T. Fujisawa, M. Suzuki, S.-i. Motohashi, K. Yasufuku, T. Yasukawa, M. Baba, and M. Shiba
Elevated Levels of Circulating Plasma Matrix Metalloproteinase 9 in Non-Small Cell Lung Cancer Patients
Clin. Cancer Res., January 1, 1999; 5(1): 149 - 153.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. Bhat-Nakshatri, T. R. Newton, R. Goulet Jr., and H. Nakshatri
NF-kappa B activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1alpha
PNAS, June 9, 1998; 95(12): 6971 - 6976.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
Z Nikolova, V Djonov, G Zuercher, A. Andres, and A Ziemiecki
Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis
J. Cell Sci., January 9, 1998; 111(18): 2741 - 2751.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
E. P. Diamandis, S. Nadkarni, B. Bhaumik, A. Abdelrahman, D. N. Melegos, G. Borchert, M. H. Black, M. Alonso, A. Salas, J. R. de los Toyos, et al.
Immunofluorometric assay of pepsinogen C and preliminary clinical applications
Clin. Chem., August 1, 1997; 43(8): 1365 - 1371.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
M. Polette, C. Gilles, V. Marchand, M. Lorenzato, B. Toole, J.-M. Tournier, S. Zucker, and P. Birembaut
Tumor Collagenase Stimulatory Factor (TCSF) Expression and Localization in Human Lung and Breast Cancers
J. Histochem. Cytochem., May 1, 1997; 45(5): 703 - 710.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Stetler-Stevenson, A. Mansoor, M. Lim, P. Fukushima, J. Kehrl, G. Marti, K. Ptaszynski, J. Wang, and W. G. Stetler-Stevenson
Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Reactive and Neoplastic Lymphoid Cells
Blood, March 1, 1997; 89(5): 1708 - 1715.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. Knauper, H. Will, C. Lopez-Otin, B. Smith, S. J. Atkinson, H. Stanton, R. M. Hembry, and G. Murphy
Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation. EVIDENCE THAT MT1-MMP (MMP-14) AND GELATINASE A (MMP-2) ARE ABLE TO GENERATE ACTIVE ENZYME
J. Biol. Chem., July 19, 1996; 271(29): 17124 - 17131.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Balbin and C. Lopez-Otin
Hormonal Regulation of the Human Pepsinogen C Gene in Breast Cancer Cells. IDENTIFICATION OF A CIS-ACTING ELEMENT MEDIATING ITS INDUCTION BY ANDROGENS, GLUCOCORTICOIDS, AND PROGESTERONE
J. Biol. Chem., June 21, 1996; 271(25): 15175 - 15181.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Society for Investigative Pathology.